carbamazepine has been researched along with Somatoform Disorders in 5 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Due to additional neuropathic pain in the lower extremities, the medication was complemented with carbamazepine." | 5.39 | [DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report]. ( Barié, A; Schiltenwolf, M; Werber, A, 2013) |
| "Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced." | 2.50 | An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder. ( Meijer, IA; Nizard, S; Robitaille, Y; Rossignol, E; Vanasse, M, 2014) |
| "Due to additional neuropathic pain in the lower extremities, the medication was complemented with carbamazepine." | 1.39 | [DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report]. ( Barié, A; Schiltenwolf, M; Werber, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dib-Hajj, SD | 1 |
| Waxman, SG | 1 |
| Werber, A | 1 |
| Schiltenwolf, M | 1 |
| Barié, A | 1 |
| Meijer, IA | 1 |
| Vanasse, M | 1 |
| Nizard, S | 1 |
| Robitaille, Y | 1 |
| Rossignol, E | 1 |
| Junewar, V | 1 |
| Sahu, R | 1 |
| Shukla, R | 1 |
| Casez, O | 1 |
| Vercueil, L | 1 |
2 reviews available for carbamazepine and Somatoform Disorders
| Article | Year |
|---|---|
Sodium Channels in Human Pain Disorders: Genetics and Pharmacogenomics.
Topics: Animals; Carbamazepine; Drug Evaluation, Preclinical; Forecasting; Ganglia, Spinal; Genetic Associat | 2019 |
An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Topics: Carbamazepine; Child, Preschool; Comorbidity; Erythromelalgia; Female; Humans; Hypesthesia; Mexileti | 2014 |
3 other studies available for carbamazepine and Somatoform Disorders
| Article | Year |
|---|---|
[DRESS syndrome. Rare and potentially lethal allergic reaction to carbamazepine - a case report].
Topics: Analgesics; Anticonvulsants; Back Pain; Carbamazepine; Comorbidity; Delayed-Action Preparations; Dia | 2013 |
Paroxysmal kinesigenic dyskinesia: a frequently misdiagnosed movement disorder.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chorea; Diagnostic Errors; Dystonia; Humans; Male; Somat | 2014 |
[Abnormal movements of psychogenic origin: usefulness of the readiness potential].
Topics: Adult; Anticonvulsants; Carbamazepine; Contingent Negative Variation; Electroencephalography; Female | 2006 |